Skip to Content

Cipla 459 (Fenofibrate 48 mg)

Pill with imprint Cipla 459 is Yellow, Elliptical / Oval and has been identified as Fenofibrate 48 mg. It is supplied by Cipla USA Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 48 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 459

Fenofibrate

Imprint
Cipla 459
Strength
48 mg
Color
Yellow
Size
12.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0459
Inactive Ingredients
microcrystalline cellulose, crospovidone, D&C Yellow No. 10, docusate sodium, FD&C Blue No. 2, FD&C Yellow No. 6, hypromellose 2910 (3 mPa.s), lactose monohydrate, soya lecithin, magnesium stearate, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.